Whetstone Capital Advisors Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Health Catalyst
HCAT
|
+$9.02M |
| 2 |
FIVE9
FIVN
|
+$7.41M |
| 3 |
Zeta Global
ZETA
|
+$6.63M |
| 4 |
NCR Voyix
VYX
|
+$5.95M |
| 5 |
Definitive Healthcare
DH
|
+$3.53M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CTV
Innovid Corp.
CTV
|
+$11.7M |
| 2 |
Paycom
PAYC
|
+$10.1M |
| 3 |
Fiverr
FVRR
|
+$7.85M |
| 4 |
CFLT
Confluent
CFLT
|
+$7.83M |
| 5 |
Atlassian
TEAM
|
+$7.68M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 69.06% |
| 2 | Healthcare | 10.29% |
| 3 | Communication Services | 10.23% |
| 4 | Consumer Discretionary | 10.17% |
| 5 | Real Estate | 0.15% |
Similar funds
Whetstone Capital Advisors's Q1 2025 Portfolio in Review
As of Q1 2025, Whetstone Capital Advisors held 40 positions worth $226M, down 27% from $310M the previous quarter. Its ten largest holdings account for 73% of the portfolio.
Whetstone Capital Advisors withdrew a net $68.5M in Q1 2025, closing 12 positions and reducing 5 holdings. Its most notable exit was Innovid Corp., an estimated $11.7M position sold in full.
By sector, the portfolio is most concentrated in Technology at 69% of assets, up from 61% a quarter earlier, followed by Healthcare and Communication Services.
Against the trend, Whetstone Capital Advisors opened a new position in Health Catalyst worth $7.72M.
- Whetstone Capital Advisors's largest Q1 2025 buy was Health Catalyst: 1,705,072 shares worth $7.72M.
- Whetstone Capital Advisors added most to Remitly in Q1 2025, an estimated $2.51M increase.
- Whetstone Capital Advisors's biggest Q1 2025 reduction was Backblaze, cutting an estimated $3.22M.
- Whetstone Capital Advisors fully exited Innovid Corp. in Q1 2025, selling an estimated $11.7M.
- Whetstone Capital Advisors's ten largest holdings make up 73% of its $226M portfolio in Q1 2025.
- Whetstone Capital Advisors opened 10 new positions and closed 12 in Q1 2025.
- Whetstone Capital Advisors's portfolio value fell 27% quarter-over-quarter to $226M.
Based on Whetstone Capital Advisors's 13F filing for Q1 2025, filed 14 May 2025.